Method
This study was conducted according to ethical standards of clinical e-research in Canada and in accordance with the Helsinki declaration. This is a retrospective analysis of clinical, biological, and echocardiographic data prospectively collected in a single center registry of all patients (n=157) who underwent percutaneous LAAC using WN devices at our institution from October 2016 to October 2021. Combined strategy was defined as a LAAC closure with WN devices associated with concomitant cardiac structural or electrophysiological interventions using the same femoral venous access.